Global Radioimmunoassays Market by Type (Coated-Tube RIA, Double-Antibody RIA), Product Type (Analyzers, Reagents & Kits), Application, End-User - Forecast 2024-2030- Product Image

Sale

Global Radioimmunoassays Market by Type (Coated-Tube RIA, Double-Antibody RIA), Product Type (Analyzers, Reagents & Kits), Application, End-User - Forecast 2024-2030

Report
183 Pages
March 2024
Region: Global
360iResearch™
ID: 5889464

UP TO €845EUR$875USD£723GBP OFF until Dec 31^st 2024

The Radioimmunoassays Market size was estimated at USD 448.94 million in 2023, USD 468.61 million in 2024, and is expected to grow at a CAGR of 4.52% to reach USD 612.00 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Radioimmunoassays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Radioimmunoassays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Radioimmunoassays Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam Plc, ALPCO, Antigenix America, Inc., Berthold Technologies GmbH & Co.KG, Biosynth Ltd, BioVendor – Laboratorni medicina a.s., Creative Biomart, Inc., Danaher Corporation, Demeditec Diagnostics GmbH, Diasorine S.P.A., DRG International, Inc. by BioCheck Inc., Drive DeVilbiss International, EUROIMMUN Medizinische Labordiagnostika AG, Hidex Oy., IBL International GmbH, Immuno-Biological Laboratories, Inc., Institute of Isotopes Co. Ltd., LKB Instruments, LubioScience GmbH, Marin Biologic Laboratories, Inc., Merck & Co, Inc, Montreal Biotech Inc., MP Biomedicals, LLC, NovoLytix GmbH, Padyab Teb Co., and PerkinElmer Inc.

Market Segmentation & Coverage

This research report categorizes the Radioimmunoassays Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Coated-Tube RIA
- Double-Antibody RIA
Product Type
- Analyzers
- Reagents & Kits
Application
- Clinical Diagnostics
- Research
End-User
- Academic & Research Institutes
- Clinical Diagnostic Laboratories
- Hospitals
- Pharmaceuticals & CROs

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Radioimmunoassays Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Radioimmunoassays Market?
What are the technology trends and regulatory frameworks in the Radioimmunoassays Market?
What is the market share of the leading vendors in the Radioimmunoassays Market?
Which modes and strategic moves are suitable for entering the Radioimmunoassays Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Radioimmunoassays Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic and infectious disease
5.1.1.2. Increasing number of imaging centers across the globe
5.1.1.3. Rapid shift towards early diagnosis and surge in healthcare expenditure
5.1.2. Restraints
5.1.2.1. Short shelf life and associated hazards concern with radioactive materials
5.1.3. Opportunities
5.1.3.1. Surge in government funding for life science research activity
5.1.3.2. Integration of advanced technology for disease diagnostics
5.1.4. Challenges
5.1.4.1. Presence of alternative advanced immunoassays and the dearth of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Radioimmunoassays Market, by Type

6.1. Introduction
6.2. Coated-Tube RIA
6.3. Double-Antibody RIA

7. Radioimmunoassays Market, by Product Type

7.1. Introduction
7.2. Analyzers
7.3. Reagents & Kits

8. Radioimmunoassays Market, by Application

8.1. Introduction
8.2. Clinical Diagnostics
8.3. Research

9. Radioimmunoassays Market, by End-User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Clinical Diagnostic Laboratories
9.4. Hospitals
9.5. Pharmaceuticals & CROs

10. Americas Radioimmunoassays Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Radioimmunoassays Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Radioimmunoassays Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abbexa Limited
14.1.2. Abcam Plc
14.1.3. ALPCO
14.1.4. Antigenix America, Inc.
14.1.5. Berthold Technologies GmbH & Co.KG
14.1.6. Biosynth Ltd
14.1.7. BioVendor - Laboratorni medicina a.s.
14.1.8. Creative Biomart, Inc.
14.1.9. Danaher Corporation
14.1.10. Demeditec Diagnostics GmbH
14.1.11. Diasorine S.P.A.
14.1.12. DRG International, Inc. by BioCheck Inc.
14.1.13. Drive DeVilbiss International
14.1.14. EUROIMMUN Medizinische Labordiagnostika AG
14.1.15. Hidex Oy.
14.1.16. IBL International GmbH
14.1.17. Immuno-Biological Laboratories, Inc.
14.1.18. Institute of Isotopes Co. Ltd.
14.1.19. LKB Instruments
14.1.20. LubioScience GmbH
14.1.21. Marin Biologic Laboratories, Inc.
14.1.22. Merck & Co, Inc
14.1.23. Montreal Biotech Inc.
14.1.24. MP Biomedicals, LLC
14.1.25. NovoLytix GmbH
14.1.26. Padyab Teb Co.
14.1.27. PerkinElmer Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. RADIOIMMUNOASSAYS MARKET RESEARCH PROCESS
FIGURE 2. RADIOIMMUNOASSAYS MARKET SIZE, 2023 VS 2030
FIGURE 3. RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RADIOIMMUNOASSAYS MARKET DYNAMICS
FIGURE 7. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 10. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. RADIOIMMUNOASSAYS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. RADIOIMMUNOASSAYS MARKET SIZE, BY COATED-TUBE RIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RADIOIMMUNOASSAYS MARKET SIZE, BY DOUBLE-ANTIBODY RIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 9. RADIOIMMUNOASSAYS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 15. RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICALS & CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 188. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 189. RADIOIMMUNOASSAYS MARKET LICENSE & PRICING

Companies Mentioned

Abbexa Limited
Abcam Plc
ALPCO
Antigenix America, Inc.
Berthold Technologies GmbH & Co.KG
Biosynth Ltd
BioVendor – Laboratorni medicina a.s.
Creative Biomart, Inc.
Danaher Corporation
Demeditec Diagnostics GmbH
Diasorine S.P.A.
DRG International, Inc. by BioCheck Inc.
Drive DeVilbiss International
EUROIMMUN Medizinische Labordiagnostika AG
Hidex Oy.
IBL International GmbH
Immuno-Biological Laboratories, Inc.
Institute of Isotopes Co. Ltd.
LKB Instruments
LubioScience GmbH
Marin Biologic Laboratories, Inc.
Merck & Co, Inc
Montreal Biotech Inc.
MP Biomedicals, LLC
NovoLytix GmbH
Padyab Teb Co.
PerkinElmer Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	183
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 468.61 Million
Forecasted Market Value ( USD ) by 2030	$ 612 Million
Compound Annual Growth Rate	4.5%
Regions Covered	Global
No. of Companies Mentioned	27

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3259EUR$3,374USD£2,787GBP €3621EUR$3,749USD£3,097GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4129EUR$4,274USD£3,530GBP €4587EUR$4,749USD£3,923GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4998EUR$5,174USD£4,274GBP €5553EUR$5,749USD£4,749GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5867EUR$6,074USD£5,017GBP €6519EUR$6,749USD£5,575GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7606EUR$7,874USD£6,504GBP €8451EUR$8,749USD£7,227GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Radioimmunoassays - Global Strategic Business Report

Radioimmunoassay Kit Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

Global Radioimmunoassay Market 2024-2028

Global Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Forecast 2024-2030

Immunodiagnostics Market Forecast to 2030 - Global Analysis by Product [Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others], Clinical Indication, End User, and Geography

About the Radioimmunoassay Market